Related Experiment Video
Updated: Dec 3, 2025

06:57
In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
Published on: February 20, 2020
8.6K
Visceral Leishmaniasis in Bolivia: Current Status
Juan Sergio Mollinedo1, Zoraida Aymara Mollinedo2, Wilson Julio Gironda3
1Instituto de Salud y Medio Ambiente, La Paz, Bolivia.
Revista Da Sociedade Brasileira De Medicina Tropical
|October 28, 2020
Summary
Visceral leishmaniasis (VL) in Bolivia has expanded to seven departments since 2014, with dogs as the primary reservoir and Lutzomyia longipalpis as the main vector. Other vectors are present where L. longipalpis is absent.
Area of Science:
- Tropical medicine
- Epidemiology
- Public health
Background:
- Limited historical data on visceral leishmaniasis (VL) in Bolivia before 1982 hindered understanding of its distribution.
- The temporospatial occurrence of VL by ecoregions, provinces, and departments in Bolivia was previously undescribed.
- Assessing VL's public health impact, outbreak risk, and dispersion required updated epidemiological data.
Purpose of the Study:
- To describe the temporospatial occurrence of visceral leishmaniasis (VL) in Bolivia.
- To evaluate the impact of VL on public health, outbreak risk, and dispersion across ecoregions.
- To update the understanding of VL epidemiology in Bolivia.
Main Methods:
- Retrospective literature review and analysis of online data, libraries, and institutional reports from 1939 to the present.
- Compilation of reported visceral leishmaniasis (VL) cases in Bolivia.
- Identification and comparison of parasites from human, canine, and vector populations in endemic areas.
Main Results:
- 56 cases of visceral leishmaniasis (VL) reported in Bolivia.
- VL endemic areas expanded from three to seven departments between 2014 and 2015.
- VL cases were identified in 12 ecoregions across the Amazon and Plata basins.
Conclusions:
- Dogs are confirmed as the primary reservoir for visceral leishmaniasis (VL).
- Lutzomyia longipalpis is the main vector, now dispersed in six departments.
- Migonemyia migonei and Lutzomyia cruzi are identified as primary vectors in areas lacking L. longipalpis.
Related Concept Videos
Pulmonary Tuberculosis III
669
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
669
Pulmonary Tuberculosis IV
309
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
309
Pulmonary Tuberculosis I
574
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
574
Pulmonary Tuberculosis II
1.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.0K
Pulmonary Tuberculosis V
349
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
349

